14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CLDX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Celldex Therapeutics stock price up 4.16% on Friday
(Updated on May 03, 2024)

Buy candidate since May 02, 2024 Gain 4.16% PDF

The Celldex Therapeutics stock price gained 4.16% on the last trading day (Friday, 3rd May 2024), rising from $40.86 to $42.56. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 3.80% from a day low at $41.34 to a day high of $42.91. The price has risen in 7 of the last 10 days and is up by 12.06% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 33 thousand more shares were traded than the day before. In total, 584 thousand shares were bought and sold for approximately $24.85 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.10% during the next 3 months and, with a 90% probability hold a price between $34.16 and $47.43 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CLDX Signals & Forecast

Mostly positive signals in the chart today. The Celldex Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $38.54 and $39.83. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 17.37%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Celldex Therapeutics stock

Celldex Therapeutics finds support from accumulated volume at $42.01 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.57 between high and low, or 3.80%. For the last week, the stock has had daily average volatility of 5.26%.

Since the Celldex Therapeutics has been rising for 6 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $40.98 (-3.72%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (CLDX) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Celldex Therapeutics to open at $42.27, and during the day (based on 14 day Average True Range), to move between $40.71 and $44.41, which gives a possible trading interval of +/-$1.85 (+/-4.35%) up or down from last closing price. If Celldex Therapeutics takes out the full calculated possible swing range there will be an estimated 8.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $42.01 (1.29%) than the resistance at $48.23 (13.32%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Celldex Therapeutics stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 3.067 Buy Candidate Unchanged

Predicted Opening Price for Celldex Therapeutics of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$42.27 ( 0.681%) $42.56

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CLDX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 43.84 3.01 %
R2 43.24 1.60 %
R1 42.87 0.728 %
Current price: 42.56
Support S1 41.67 -2.09 %
S2 41.30 -2.96 %
S3 40.70 -4.37 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 51.88 21.90 %
R2 50.01 17.50 %
R1 48.23 13.32 %
Current price 42.56
Support S1 42.01 -1.29%
S2 37.75 -11.30%
S3 36.26 -14.80%

FAQ

What is the symbol for Celldex Therapeutics Stock and on which exchange is it traded?
The symbol for Celldex Therapeutics is CLDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Celldex Therapeutics Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

How to buy Celldex Therapeutics Stock?
Celldex Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Celldex Therapeutics Stock.

What's the current price of Celldex Therapeutics Stock?
As of the end of day on the May 03, 2024, the price of an Celldex Therapeutics (CLDX) share was $42.56.

What is the 52-week high and low for Celldex Therapeutics Stock?
The 52-week high for Celldex Therapeutics Stock is $53.18 and the 52-week low is $22.11.

What is the market capitalization of Celldex Therapeutics Stock?
As of the May 03, 2024, the market capitalization of Celldex Therapeutics is 2.805B.

When is the next earnings date for Celldex Therapeutics?
The upcoming earnings date for Celldex Therapeutics is Aug 06, 2024.
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT